Janux Therapeutics (JANX) EBITDA Margin (2021 - 2026)
Janux Therapeutics (JANX) reported EBITDA Margin of 752.77% for Q1 2026, down 220.36% on a QoQ basis from 234.98% in Q3 2025.
Janux Therapeutics (JANX) has 6 years of EBITDA Margin data on file, last reported at 752.77% in Q1 2026.
- Quarterly EBITDA Margin changed N/A year-over-year to 752.77% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 856.75% (down 6989.0% YoY) and the FY2025 annual result came in at 1114.72%, down 47724.0% from the prior year.
- EBITDA Margin retreated to 752.77% in Q1 2026 per JANX's latest filing, from 234.98% in the prior quarter.
- Across five years, EBITDA Margin topped out at 79.25% in Q2 2024 and bottomed at 4239.64% in Q3 2024.
- The 5-year median for EBITDA Margin is 752.77% (2026), against an average of 1007.61%.
- The widest annual swing landed in 2024, when EBITDA Margin tumbled 377547 bps; it then jumped 400466 bps in 2025.
- Tracing JANX's EBITDA Margin over 5 years: stood at 538.59% in 2022, then gained by 25 bps to 403.01% in 2023, then plunged by 952 bps to 4239.64% in 2024, then jumped by 94 bps to 234.98% in 2025, then slumped by 220 bps to 752.77% in 2026.
- Per Business Quant, the three latest JANX EBITDA Margin figures stand at 752.77% (Q1 2026), 234.98% (Q3 2025), and 4239.64% (Q3 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -6.43% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 38.10% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 18.35% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 17.24% |
| 10 | Janux Therapeutics | 914.29 Mn | 914.29 Mn | - | -752.77% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -752.77% |
| Sep 30, 2025 | -234.98% |
| Sep 30, 2024 | -4,239.64% |
| Jun 30, 2024 | -79.25% |
| Mar 31, 2024 | -1,273.88% |
| Dec 31, 2023 | -403.01% |
| Sep 30, 2023 | -464.16% |
| Jun 30, 2023 | -1,686.75% |
| Mar 31, 2023 | -813.62% |
| Dec 31, 2022 | -538.59% |
| Sep 30, 2022 | -941.31% |
| Jun 30, 2022 | -728.46% |
| Mar 31, 2022 | -942.54% |
| Dec 31, 2021 | -848.39% |
| Sep 30, 2021 | -928.30% |
| Jun 30, 2021 | -1,284.02% |
| Mar 31, 2021 | -601.05% |